|1.||Moberg, Paul J: 5 articles (12/2012 - 04/2005)|
|2.||Turetsky, Bruce I: 4 articles (12/2012 - 04/2005)|
|3.||Kanes, Stephen J: 3 articles (12/2012 - 04/2005)|
|4.||Gur, Raquel E: 3 articles (12/2012 - 04/2005)|
|5.||Balderston, Catherine C: 3 articles (09/2007 - 04/2005)|
|6.||Roalf, David R: 3 articles (09/2007 - 04/2005)|
|7.||Compton, Michael T: 2 articles (08/2013 - 09/2007)|
|8.||Walker, Elaine F: 2 articles (08/2013 - 09/2007)|
|9.||Sharma, K: 2 articles (10/2008 - 06/2004)|
|10.||Nishii, Ryuichi: 1 article (06/2015)|
08/01/1990 - "Possible relations between sensitivity to phenylthiocarbamide and goiter."
11/11/1966 - "[The phenylthiocarbamide test in subjects with malignant goiter]."
06/01/1975 - "I. Demographic study on the relation of taste distinction of PTC (Phenylthiocarbamide) to the quantity and quality of goiter in 61,490 subjects in Czechoslovakia]."
01/01/1968 - " The effect of the treatment of established goiters in adolescent girls with thyroxine is described, as are results of the studies of the ability to taste phenylthiocarbamide, a property which may be genetically linked to a predisposition to goiter. "
|2.||Melanoma (Melanoma, Malignant)
12/13/1999 - "Inhibition of L-tyrosine-induced micronuclei production by phenylthiourea in human melanoma cells."
03/31/1992 - "Phenylthiourea, a specific inhibitor of tyrosinase activity, partially blocked the growth inhibitory activity of N-Ac-4-S-CAP in human pigmented melanoma cells. "
09/15/2008 - "We tested this concept in human melanoma cells cultured in either Ham's F10 medium to maintain amelanotic phenotype or DMEM to induce/stimulate melanin production, respectively; N-phenylthiourea (PTU) and D-penicillamine were used as an inhibitor of melanogenesis. "
12/13/1999 - "L-Tyrosine oxidation product(s) increased the frequency of micronuclei in melanoma cells; 0.1 mM phenylthiourea (PTU), an inhibitor of L-tyrosine oxidation by tyrosinase, lowered the micronucleus production to the control levels. "
01/01/1990 - "Phenylthiocarbamide, an inhibitor of tyrosinase activity, selectively decreased VP-16 toxicity only in melanoma cells. "
04/01/1968 - "Phenylthiourea taste blindness and MMPI personality patterns in adult Caucasion females."
09/01/1951 - "Concerning taste-blindness to phenylthiocarbamide."
01/01/1951 - ""Taste blindness" to phenylthiocarbamide and related compounds."
02/01/2007 - "The inability to taste phenylthiocarbamide (PTC; "taste-blindness") has been associated with a number of medical and neurological illnesses not typically related to taste. "
11/30/1998 - "Taste blindness to phenylthiocarbamide (PTC) and its chemical relative 6-n-propylthiouracil (PROP) was discovered in the 1930s. "
05/01/2015 - "Phenylthiocarbamide taste perception as a possible genetic association marker for nutritional habits and obesity tendency of people."
05/01/2015 - "Relating taste perception to obesity, the present study was undertaken to assess the prevalence of phenylthiocarbamide (PTC) taste blindness among obese individuals. "
|5.||Duodenal Ulcer (Curling's Ulcer)
07/01/1990 - "This study examined phenylthiocarbamide taste sensitivity in gastric and duodenal ulcer disease. "
01/01/1985 - "Duodenal ulcer: genetic analysis by the phenylthiocarbamide test."
07/01/1990 - "The difference between gastric and duodenal ulcer patients in the ability to taste phenylthiocarbamide may be genetic; however, this study's inability, despite substantial power, to detect at least a twofold difference between patients and controls suggests that if phenylthiocarbamide taste sensitivity is a genetic factor in peptic ulcer, the relationship is weak."
|1.||Factor IX (PTC)
|2.||Monophenol Monooxygenase (Tyrosinase)
|7.||Egtazic Acid (EGTA)
|8.||Edetic Acid (EDTA)